InvestorsHub Logo
Followers 9
Posts 468
Boards Moderated 0
Alias Born 11/26/2016

Re: sts66 post# 237782

Monday, 12/30/2019 1:32:12 PM

Monday, December 30, 2019 1:32:12 PM

Post# of 429056
https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-patent-litigation-settlement-agreement-teva

The press release says "As part of the settlement agreement, Teva may first begin selling its generic version of Vascepa in the United States on August 9, 2029, or earlier under certain customary circumstances."

Common sense that their entry could change if their competition received the OK to enter the market.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News